Print

Purpose

This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.

Condition

Eligibility

Eligible Ages
Over 45 Years
Eligible Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Self-identified Black individuals ≥ 45 years with an intact uterus - Assigned female sex at birth - Experience with abnormal uterine or post-menopausal bleeding (defined as vaginal bleeding between periods, heavy vaginal bleeding, vaginal bleeding after menopause, and/or red, brown, or pink colored vaginal discharge after menopause) - Willing to participate in a 45-minute virtual interview

Exclusion Criteria

  • Previous or current diagnosis of endometrial cancer

Study Design

Phase
Study Type
Observational
Observational Model
Case-Only
Time Perspective
Cross-Sectional

Arm Groups

ArmDescriptionAssigned Intervention
Observational Participants complete a semi-structured interview on study.
  • Other: Non-Interventional Study
    Non-interventional study
    Other names:
    • Non-Interventional Observational Study
    • Noninterventional (Observational) Study

Recruiting Locations

Mayo Clinic in Rochester
Rochester, Minnesota 55905
Contact:
Clinical Trials Referral Office
855-776-0015

More Details

Status
Recruiting
Sponsor
Mayo Clinic

Study Contact

Clinical Trials Referral Office
855-776-0015
mayocliniccancerstudies@mayo.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.